Pacific Edge (ASX:PEB, NZE:PEB) requested that its securities be placed in trading halt ahead of the market open on Friday until an announcement is made about the implications of a draft Local Coverage Determination (LCD) by Novitas, according to a same-day filing with the Australian bourse.
The LCD concerns Medicare's reimbursement of the company's Cxbladder bladder cancer detection test, the filing said.
The trading halt will remain in place until the start of trading on the Australian Securities Exchange and the New Zealand Stock Exchange on Jan. 13, per the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。